Literature DB >> 9798860

Acute renal failure after arteriography with a gadolinium-based contrast agent.

J Gemery1, B Idelson, S Reid, E K Yucel, H Pagan-Marin, S Ali, L Casserly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9798860     DOI: 10.2214/ajr.171.5.9798860

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  6 in total

1.  Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up.

Authors:  Edwin A Takahashi; David F Kallmes; Kristin C Mara; William S Harmsen; Sanjay Misra
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

2.  Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors.

Authors:  Catherine Do; Bridget Ford; Doug Yoon Lee; Chunyan Tan; Patricia Escobar; Brent Wagner
Journal:  Toxicol Appl Pharmacol       Date:  2019-05-10       Impact factor: 4.219

3.  Management of transplant renal artery stenosis.

Authors:  Dheeraj K Rajan; S William Stavropoulos; Richard D Shlansky-Goldberg
Journal:  Semin Intervent Radiol       Date:  2004-12       Impact factor: 1.513

Review 4.  The kidney and the elderly: why does the risk increase?

Authors:  Pierangela Presta; Gaetano Lucisano; Laura Fuiano; Giorgio Fuiano
Journal:  Int Urol Nephrol       Date:  2011-10-14       Impact factor: 2.370

5.  One-molar gadolinium chelate (gadobutrol) as a contrast agent for CT angiography of the thoracic and abdominal aorta.

Authors:  José M Esteban; Antonio Alonso; Vicente Cervera; Vicente Martínez
Journal:  Eur Radiol       Date:  2007-02-07       Impact factor: 5.315

Review 6.  Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

Authors:  Jeffrey C Weinreb; Roger A Rodby; Jerry Yee; Carolyn L Wang; Derek Fine; Robert J McDonald; Mark A Perazella; Jonathan R Dillman; Matthew S Davenport
Journal:  Kidney Med       Date:  2020-11-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.